Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia
March 2015
in “Dermatologic Therapy”
TLDR Latanoprost may cause scalp inflammation and delayed healing.
The article reports a case of a 61-year-old woman who developed erosive pustular dermatosis of the scalp (EPDS) after using topical latanoprost for androgenetic alopecia. EPDS is an inflammatory chronic disease that leads to scarring alopecia. Although trauma is known to precipitate this condition, topical latanoprost has not previously been reported as a triggering factor. The authors suggest that EPDS should be considered in any subject developing a chronic inflammatory response or delayed healing after latanoprost treatment. More research is needed to determine the efficacy and safety of latanoprost or other prostaglandin analogs for hair growth.
View this study on onlinelibrary.wiley.com →
Cited in this study
research A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
Latanoprost 0.1% may effectively treat hair loss.
Related
research Lichen‐planopilaris‐like scarring pattern in a patient with alopecia and pityriasis rubra pilaris
A patient with a skin condition had unusual scarring hair loss but improved with treatment.
research Incidental Syringomas of the Scalp in a Patient with Scarring Alopecia
A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.
research Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia
Latanoprost may cause scalp inflammation and delayed healing.